The cost-effectiveness of harm reduction

Highlights • OST, NSPs and ART are effective, reduce risk and improve quality of life. • There is no evidence that compulsory detention reduces drug dependency. • The unit costs of harm reduction interventions are relatively low. • Harm reduction is good value for money, at $100–1000 per HIV infecti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The International journal of drug policy 2015-02, Vol.26, p.S5-S11
Hauptverfasser:	Wilson, David P, Donald, Braedon, Shattock, Andrew J, Wilson, David, Fraser-Hurt, Nicole
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-HIV Agents - therapeutic use Antiretroviral drugs Clinical outcomes Cost reduction Cost-Benefit Analysis Cost-effectiveness Disease control Drug policy Drug therapy Effectiveness studies Global Health Harm Reduction HIV HIV Infections - economics HIV Infections - epidemiology HIV Infections - prevention & control Human immunodeficiency virus Humans Internal Medicine Medical Education Needle-Exchange Programs - economics Needle-Exchange Programs - organization & administration Opiate Substitution Treatment - economics Opiate Substitution Treatment - methods People who inject drugs Prevalence Substance Abuse, Intravenous - complications Substance Abuse, Intravenous - economics Substance Abuse, Intravenous - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • OST, NSPs and ART are effective, reduce risk and improve quality of life. • There is no evidence that compulsory detention reduces drug dependency. • The unit costs of harm reduction interventions are relatively low. • Harm reduction is good value for money, at $100–1000 per HIV infection averted. • Harm reduction coverage is too low. Scale up will yield returns on investment.
ISSN:	0955-3959 1873-4758
DOI:	10.1016/j.drugpo.2014.11.007